IDRA-21: A Comprehensive Overview of its Nootropic Properties
IDRA-21, also known as 2-Amino-5-Isoxazole Propionic Acid, is a nootropic compound that has been studied for its potential cognitive-enhancing effects. It is a derivative of the neurotransmitter glutamate, and is thought to act as a positive allosteric modulator of the AMPA receptor. This article will provide an overview of the research on IDRA-21, including its potential benefits, possible side effects, and recommended dosage.
IDRA-21 is a synthetic compound that is structurally similar to the neurotransmitter glutamate. It is thought to act as a positive allosteric modulator of the AMPA receptor, which is involved in the transmission of signals between neurons. This means that it can increase the activity of the receptor, leading to increased communication between neurons and improved cognitive function.
- May improve memory and learning
- May increase focus and concentration
- May reduce anxiety and stress
- May improve mood and motivation
Possible Negative Effects
- May cause headaches
- May cause nausea
- May cause insomnia
- May cause irritability
The recommended dosage of IDRA-21 is 10-20 mg per day. It is important to start with a low dose and gradually increase it to avoid any potential side effects.
IDRA-21 was first synthesized in the early 2000s and has since been studied for its potential cognitive-enhancing effects. It has been found to be effective in animal studies, and is currently being studied in human clinical trials.
Overall, IDRA-21 is a promising nootropic compound that may have a variety of cognitive-enhancing effects. It is important to note, however, that more research is needed to fully understand its potential benefits and side effects.